Director, UK Revenue & Margin
13 hours ago
Uxbridge
Company description: OXB is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, OXB has more than 30 years of experience in viral vectors, the driving force behind the majority of gene therapies. Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient's cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients' cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy). OXB collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXB's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise. Job description: Join Us in Changing Lives At OXB , our people are at the heart of everything we do. We're on a mission to enable life-changing therapies to reach patients around the world—and we're looking for passionate individuals who embody our core values every day: Responsible, Responsive, Resilient, and Respectful . We're currently recruiting for a Director, UK Revenue & Margin Manager to join our Finance team . In this role, you will take ownership of the financial performance and control of a complex manufacturing operation , leading manufacturing cost accounting and reporting , playing a key part in advancing our mission and making a real difference. Your responsibilities in this role would be to: Lead and own the financial accounting, reporting and analysis of revenue, gross margin, cost of sales, inventory, contract assets and manufacturing-related balance sheet accounts, ensuring robust financial control and insightful performance reporting. Act as the finance lead for manufacturing performance, analysing production costs, labour utilisation, inventory movements, absorption rates and operational variances to identify opportunities for improved efficiency and profitability. Lead, coach and develop a small team of finance professionals, creating a culture of accountability, continuous improvement and technical excellence while remaining actively involved in the detail when required. Prepare reporting, commentary and technical financial analysis for monthly, interim and year-end reporting requirements. Partner with senior leaders across Manufacturing, Supply Chain, Operations and Commercial functions, providing financial insight, challenge and recommendations that influence key business decisions. Support budgeting and forecasting activities relating to revenue, margin and associated operating expenditure. Maintain key financial controls, support audit requirements and ensure compliance with accounting standards and company policies. Take ownership of revenue accounting activities, including intercompany transactions, cost of sales, inventory, contract assets and liabilities, and project financial controls We are looking for: ACA, ACCA or CIMA qualified accountant with experience in a corporate finance environment. Significant experience within a manufacturing, engineering, pharmaceutical, biotechnology or other product-based environment, with expert knowledge of cost accounting, inventory accounting, gross margin analysis and financial control. Demonstrable experience partnering operational and manufacturing leaders to improve business performance through financial insight and analysis. Proven people management experience with the ability to develop and lead teams effectively. Strong analytical skills with the ability to translate financial data into meaningful business insight. Experience working with ERP systems and advanced Microsoft Excel skills. About Us: OXB (LSE: OXB) is a global quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, OXB has 30 years of experience in viral vectors; the driving force behind the majority of cell and gene therapies. OXB collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV), adenovirus and other viral vector types. OXB's world-class capabilities range from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise. OXB offers a vast number of technologies for viral vector manufacturing, including a 4th generation lentiviral vector system (the TetraVecta™ system), a dual-plasmid system for AAV production, suspension and perfusion process using process enhancers and stable producer and packaging cell lines. OXB, a FTSE250 and FTSE4Good constituent, is headquartered in Oxford, UK. It has development and manufacturing facilities across Oxfordshire, UK, Lyon and Strasbourg, France, Bedford MA, and Durham NC, US. Why Join Us? ?? Competitive total reward packages ?? Wellbeing programs that support your mental and physical health ?? Career development opportunities to help you grow and thrive ?? Supportive, inclusive, and collaborative culture ?? State-of-the-art labs and manufacturing facilities ?? A company that lives its values: Responsible, Responsive, Resilient, Respect We want you to feel inspired every day. At OXB, we're future-focused and growing fast. We succeed together—through passion, commitment, and teamwork. Ready to Make a Difference? The closing date for applications is 20th November 2026. Please note: Our vacancies are typically advertised for a minimum of 10 working days. Once a vacancy closes, it may take a few days for us to provide an update while our Talent Acquisition team and hiring managers review all applications. Every application is reviewed manually by our recruitment team and hiring managers. We do not use AI to screen CVs or make shortlisting decisions. We offer: Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies. Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient's cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients' cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy). Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise. TPBN1_UKTJ